Search research articles
Contact Us
Filters
Showing results (1-10 of 61) with videos related to
Page
of 7
Sort By:
Journal of Molecular Medicine (Berlin, Germany)
|
August 6, 2016
The molecular mechanism of thalidomide analogs in hematologic malignancies
Stefanie Lindner, Jan Krönke
Cancers
|
December 17, 2020
Ubiquitination and Ubiquitin-Like Modifications in Multiple Myeloma: Biology and Therapy
Matthias Wirth, Markus Schick, Ulrich Keller, et al.
Oncoimmunology
|
January 23, 2015
Lenalidomide induces degradation of IKZF1 and IKZF3
Jan Krönke, Slater N Hurst, Benjamin L Ebert
Acta Haematologica
|
September 18, 2025
Donor-Derived Clonal Haematopoiesis after Allogeneic Stem-Cell Transplantation: A Case Report
Adrian Schwarzer, Christian Späth, Thomas Neumann, et al.
Case Reports in Hematology
|
January 9, 2023
Relapse of <i>NPM1</i>-Mutated AML with Extramedullary Manifestation 17 Years after Allogeneic Hematopoietic Stem Cell Transplantation
Jan Braune, Kathrin Rieger, Olga Blau, et al.
Hemasphere
|
March 4, 2024
CDK6 protein expression is associated with disease progression and treatment resistance in multiple myeloma
Johannes Steinhart, Peter Möller, Miriam Kull, et al.
Journal of Visualized Experiments : Jove
|
June 4, 2019
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Stefanie Lindner, Christian Steinebach, Hannes Kehm, et al.
Cancers
|
January 25, 2025
PROTAC-Mediated GSPT1 Degradation Impairs the Expression of Fusion Genes in Acute Myeloid Leukemia
Alicia Perzolli, Christian Steinebach, Jan Krönke, et al.
Journal of Virology
|
March 16, 2004
Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs
Jan Krönke, Ralf Kittler, Frank Buchholz, et al.
Nature Communications
|
December 19, 2023
Direct-to-biology, automated, nano-scale synthesis, and phenotypic screening-enabled E3 ligase modulator discovery
Zefeng Wang, Shabnam Shaabani, Xiang Gao, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 61) with videos related to
Sort By:
Page
of 7
Journal of Molecular Medicine (Berlin, Germany)
|
August 6, 2016
The molecular mechanism of thalidomide analogs in hematologic malignancies
Stefanie Lindner, Jan Krönke
Cancers
|
December 17, 2020
Ubiquitination and Ubiquitin-Like Modifications in Multiple Myeloma: Biology and Therapy
Matthias Wirth, Markus Schick, Ulrich Keller, et al.
Oncoimmunology
|
January 23, 2015
Lenalidomide induces degradation of IKZF1 and IKZF3
Jan Krönke, Slater N Hurst, Benjamin L Ebert
Acta Haematologica
|
September 18, 2025
Donor-Derived Clonal Haematopoiesis after Allogeneic Stem-Cell Transplantation: A Case Report
Adrian Schwarzer, Christian Späth, Thomas Neumann, et al.
Case Reports in Hematology
|
January 9, 2023
Relapse of <i>NPM1</i>-Mutated AML with Extramedullary Manifestation 17 Years after Allogeneic Hematopoietic Stem Cell Transplantation
Jan Braune, Kathrin Rieger, Olga Blau, et al.
Hemasphere
|
March 4, 2024
CDK6 protein expression is associated with disease progression and treatment resistance in multiple myeloma
Johannes Steinhart, Peter Möller, Miriam Kull, et al.
Journal of Visualized Experiments : Jove
|
June 4, 2019
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Stefanie Lindner, Christian Steinebach, Hannes Kehm, et al.
Cancers
|
January 25, 2025
PROTAC-Mediated GSPT1 Degradation Impairs the Expression of Fusion Genes in Acute Myeloid Leukemia
Alicia Perzolli, Christian Steinebach, Jan Krönke, et al.
Journal of Virology
|
March 16, 2004
Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs
Jan Krönke, Ralf Kittler, Frank Buchholz, et al.
Nature Communications
|
December 19, 2023
Direct-to-biology, automated, nano-scale synthesis, and phenotypic screening-enabled E3 ligase modulator discovery
Zefeng Wang, Shabnam Shaabani, Xiang Gao, et al.
Page
of 7